COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| (USD) | Mar 26 | Jun 26 | Trend |
|---|---|---|---|
| Cash & Equivalents | 49.86M | 237.37M | |
| Receivables | 1.43M | 1.82M | |
| Current Assets | 169.43M | 464.00M | |
| Net PP&E | 1.59M | 1.50M | |
| Total Assets | 175.26M | 467.78M | |
| Current Liabilities | 13.19M | 12.94M | |
| Total Debt | 1.06M | 1.03M | |
| Total Liabilities | 373.88M | 13.51M | |
| Retained Earnings | -204.54M | -228.69M | |
| Shareholders Equity | -198.62M | 454.27M | |
| Working Capital | 156.24M | 451.05M | |
| Shares Outstanding | 44.19M | 46.71M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--